News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Positive Results in SHARP Trial for Merck & Co., Inc. (MRK)


11/22/2010 6:58:44 AM

Benzinga -- Deutsche Bank has published a company alert today on Merck & Co. following results of the SHARP trial. In a note to clients, Deutsche Bank writes, "The SHARP trial compared vascular/atherosclerotic outcomes with Vytorin 10/20 therapy to placebo in 9,400 chronic kidney disease patients (approx. 1/3 on dialysis) with 5 years of followup. Results were positive overall, and no major safety concerns emerged, suggesting that MRK will be able to gain approval for the supplemental indication."

Read at News Release
Read at nj.com
Read at News Release
Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES